North America Aptamers Market

North America Aptamers Market Size (2023 to 2028)

The size of the North American aptamers market size is predicted to be worth USD 194.8 million by 2028 from USD 90.7 million in 2023, growing at a CAGR of 16.5% from 2023 to 2028.

The aptamers market in the North American region is majorly driven by the increasing incidence of life-threatening diseases like cancer and increasing research and development activities. For example, cancer has prompted many companies to develop novel and effective detection tests based on aptamer treatment. In addition, the major pharmaceutical and biotechnology industries are investing in research and development activities which are expected to encourage market growth.  

The market growth is further estimated to be driven by the low cost and high efficiency of Aptamers to large molecules to antibodies. Also, the numerous benefits that these small molecules provide over conventional antibodies have resulted in increased demand for these compounds in various medicinal applications. In addition, they're chemically produced, so there's no batch-to-batch variance, and development takes less time.

On the other hand, the advancements in aptamer development technologies and the availability of advancements in the healthcare infrastructure are fuelling market growth. For example, Ultramers, a new product from Integrated DNA Technologies, Inc., comprises aptamer templates with lengths of up to 200 bases. According to the company, this new product will be ideal for biotechnology applications such as gene and clone creation. As a result, recent advancements in this industry are projected to increase the use of these goods in various applications, resulting in market growth.

Moreover, the increasing investments and funding by the government and private organizations for developing healthcare infrastructure are also expected to contribute to market growth. 

On the other hand, many aptamers have failed to meet clinical trials' safety and effectiveness requirements. As a result, during late-stage clinical investigations, businesses must stop clinical research. This aspect is expected to have a negative impact on the market's growth. Furthermore, additional issues such as a lack of awareness of these technologies in middle- and low-income countries and an insufficient regulatory structure may hinder overall expansion.

This research report has segmented and sub-segmented the North American aptamers market into the following categories:

By Type:

• Peptide aptamers
• Nucleic Acid aptamers
  • DNA-Based Aptamers
  • RNA-Based Aptamers
  • XNA-Based Aptamers

By Application:

• Therapeutics Development
• Diagnostics
• Research and Development

By End User:

• Pharmaceutical Companies
• Bio-Pharmaceutical companies
• Academic and Research Centres

By Country: 

• The United States
• Canada
• Rest of North America

Geographically, the North American aptamers market dominated the global market in 2022 and is estimated to register a healthy CAGR during the forecast period due to the availability of advanced healthcare infrastructure, technological advancements, and increasing pharmaceutical and biotechnology industries' investments in research and development activities. As a result, aptamers are now being utilized to diagnose various diseases and detect tiny compounds. In addition, aptamers can be utilized as functional proteomic levels and pharmaceutical lead section reagents. Also, the presence of the largest economies such as the U.S. and Canada significantly contributes to the North American market growth.

The U.S. aptamers market is anticipated to witness a prominent share in the Aptamers Market. The advancing healthcare sector, favorable reimbursement policies, and the increased applications of aptamers in the food and chemicals industries are fuelling the Aptamers market. In addition, the key market players are investing in R&D activities which are expected to provide lucrative growth opportunities for the new market players.

On the other hand, the Canadian Aptamers market is projected to record a promising share and contribute to the North American regional market growth. The rising focus on the research and development activities in biotechnology and the pharmaceutical sector to introduce innovative pharmaceutical drugs. Increasing demand for aptamers and related products from research institutions is expected to drive market growth.

KEY MARKET PLAYERS:

Companies playing a prominent role in the North American aptamers market profiled in this report are AM Biotechnologies, Aptagen, Aptamer Sciences Inc, Aptamer Solutions Ltd, Aptus Biotech S.L, Base Pair Biotechnologies Inc, NeoVentures Biotechnology Inc, SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.